Follow
Paolo Lombardi
Paolo Lombardi
Naxospharma SRL
Verified email at naxospharma.eu
Title
Cited by
Cited by
Year
Berberine: new perspectives for old remedies
M Tillhon, LMG Ortiz, P Lombardi, AI Scovassi
Biochemical pharmacology 84 (10), 1260-1267, 2012
4512012
Berberine, an epiphany against cancer
LM Guamán Ortiz, P Lombardi, M Tillhon, AI Scovassi
Molecules 19 (8), 12349-12367, 2014
2682014
Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs
JA McCubrey, K Lertpiriyapong, LS Steelman, SL Abrams, LV Yang, ...
Aging (Albany NY) 9 (6), 1477, 2017
2102017
6-Methylenandrosta-1, 4-diene-3, 17-dione (FCE 24304): a new irreversible aromatase inhibitor
D Giudici, G Ornati, G Briatico, F Buzzetti, P Lombardi, E Di Salle
Journal of steroid biochemistry 30 (1-6), 391-394, 1988
1661988
New developments in antitumor anthracyclines
F Arcamone, F Animati, G Capranico, P Lombardi, G Pratesi, S Manzini, ...
Pharmacology & therapeutics 76 (1-3), 117-124, 1997
1371997
Synthesis of aryl 2-benzofuranyl and aryl 2-indolyl carbinols of high enantiomeric purity via palladium-catalyzed heteroannulation of chiral arylpropargylic alcohols
M Botta, V Summa, F Corelli, G Di Pietro, P Lombardi
Tetrahedron: Asymmetry 7 (5), 1263-1266, 1996
1271996
Exemestane, a new steroidal aromatase inhibitor of clinical relevance
P Lombardi
Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1587 (2-3 …, 2002
952002
Doxorubicin Disaccharide Analogue: Apoptosis-Related Improvement of Efficacy In Vivo
F Arcamone, F Animati, M Berettoni, M Bigioni, G Capranico, AM Casazza, ...
JNCI: Journal of the National Cancer Institute 89 (16), 1217-1223, 1997
861997
Biophysical studies on the effect of the 13 position substitution of the anticancer alkaloid berberine on its DNA binding
D Bhowmik, M Hossain, F Buzzetti, R D’Auria, P Lombardi, GS Kumar
The Journal of Physical Chemistry B 116 (7), 2314-2324, 2012
842012
Multiple effects of berberine derivatives on colon cancer cells
LM Guaman Ortiz, M Tillhon, M Parks, I Dutto, E Prosperi, M Savio, ...
BioMed research international 2014, 2014
762014
Berberine acts as a natural inhibitor of Wnt/β‐catenin signaling—Identification of more active 13‐arylalkyl derivatives
KF Albring, J Weidemüller, S Mittag, J Weiske, K Friedrich, MC Geroni, ...
Biofactors 39 (6), 652-662, 2013
662013
Antiangiogenic and antitumor activities of berberine derivative NAX014 compound in a transgenic murine model of HER2/neu-positive mammary carcinoma
E Pierpaoli, E Damiani, F Orlando, G Lucarini, B Bartozzi, P Lombardi, ...
Carcinogenesis 36 (10), 1169-1179, 2015
602015
6-substituted androsta-1, 4-diene-3, 17-diones
F Buzzetti, N Barbugian, P Lombardi, EDI Salle
US Patent 4,808,616, 1989
581989
Antitumor effect of novel berberine derivatives in breast cancer cells
E Pierpaoli, AG Arcamone, F Buzzetti, P Lombardi, C Salvatore, ...
Biofactors 39 (6), 672-679, 2013
562013
Substituted 1-[(benzofuran-2-yl)-phenylmethyl]-imidazoles as potent inhibitors of aromatase in vitro and in female rats in vivo
R Whomsley, E Fernandez, PJ Nicholls, HJ Smith, P Lombardi, ...
The Journal of Steroid Biochemistry and Molecular Biology 44 (4-6), 675-676, 1993
561993
Effect of new berberine derivatives on colon cancer cells
LM Guamán Ortiz, AL Croce, F Aredia, S Sapienza, G Fiorillo, TM Syeda, ...
Acta biochimica et biophysica Sinica 47 (10), 824-833, 2015
552015
Modulation of the expression of folate cycle enzymes and polyamine metabolism by berberine in cisplatin-sensitive and-resistant human ovarian cancer cells
G Marverti, A Ligabue, P Lombardi, S Ferrari, MG Monti, C Frassineti, ...
International Journal of Oncology 43 (4), 1269-1280, 2013
552013
Metformin influences drug sensitivity in pancreatic cancer cells
S Candido, SL Abrams, L Steelman, K Lertpiriyapong, AM Martelli, ...
Advances in biological regulation 68, 13-30, 2018
522018
Large scale preparation of enantiopure S-ketoprofen by biocatalysed kinetic resolution
N D’Antona, P Lombardi, G Nicolosi, G Salvo
Process Biochemistry 38 (3), 373-377, 2002
502002
4-Aminoandrostenedione derivatives: a novel class of irreversible aromatase inhibitors. Comparison with FCE 24304 and 4-hydroxyandrostenedione
E Di Salle, D Giudici, G Ornati, G Briatico, R D'alessio, V Villa, P Lombardi
The Journal of Steroid Biochemistry and Molecular Biology 37 (3), 369-374, 1990
471990
The system can't perform the operation now. Try again later.
Articles 1–20